Medical Innovation Exchange

Amgen hits pause on $400M eczema bet to tweak phase 3 study

https://www.fiercebiotech.com/biotech/amgen-hits-pause-400m-eczema-bet-tweak-phase-3-study

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!